Overview
Introduction
A patient whose diarrhoea returns after treatment may have recurrent C.
CNPLE
CNPLE
A patient whose diarrhoea returns after treatment may have recurrent C. difficile infection, but a positive PCR alone does not establish that diagnosis. The clinical question is whether active, toxin-producing disease has returned in a symptomatic patient, and whether the illness is severe or fulminant. Treatment decisions then depend on recurrence history, drug safety, local Canadian guidance, and access to fidaxomicin. AMMI Canada places oral vancomycin first-line, while the US IDSA/SHEA guideline prefers fidaxomicin when available; this difference reflects Canadian cost and coverage constraints rather than evidence that fidaxomicin is ineffective. [1,2,7]
Unlock full lesson + practice questions
7 more sections with scenarios, priorities, and review drills.
Final rapid review before practice
Next study step
Finish the lesson first, then choose a focused activity to apply what you just reviewed.
Continue studying
Sign in to save progress on this lesson.
Unlock the interactive lesson quiz with a plan that includes this CNPLE pathway. You can still explore topic-filtered questions from the bank hubs below.